BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27834793)

  • 1. B Cell Receptor Affinity for Insulin Dictates Autoantigen Acquisition and B Cell Functionality in Autoimmune Diabetes.
    Packard TA; Smith MJ; Conrad FJ; Johnson SA; Getahun A; Lindsay RS; Hinman RM; Friedman RS; Thomas JW; Cambier JC
    J Clin Med; 2016 Nov; 5(11):. PubMed ID: 27834793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of the repertoire of insulin-reactive B cells in type 1 diabetes-prone and resistant mice.
    Banach M; Harley ITW; Getahun A; Cambier JC
    Front Immunol; 2022; 13():961209. PubMed ID: 36275764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-cell delivered gene therapy for tolerance induction: role of autoantigen-specific B cells.
    Zhang AH; Li X; Onabajo OO; Su Y; Skupsky J; Thomas JW; Scott DW
    J Autoimmun; 2010 Sep; 35(2):107-13. PubMed ID: 20579844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Governing B Cell Recognition of Autoantigen and Function in Type 1 Diabetes.
    Bass LE; Bonami RH
    Antibodies (Basel); 2024 Apr; 13(2):. PubMed ID: 38651407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble Antigen Arrays for Selective Desensitization of Insulin-Reactive B Cells.
    Leon MA; Wemlinger SM; Larson NR; Ruffalo JK; Sestak JO; Middaugh CR; Cambier JC; Berkland C
    Mol Pharm; 2019 Apr; 16(4):1563-1572. PubMed ID: 30681867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Anti-Insulin B Cell Receptors Improves Receptor Editing in Type 1 Diabetes-Prone Mice.
    Bonami RH; Thomas JW
    J Immunol; 2015 Nov; 195(10):4730-41. PubMed ID: 26432895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantigen-specific B-cell depletion overcomes failed immune tolerance in type 1 diabetes.
    Henry RA; Kendall PL; Thomas JW
    Diabetes; 2012 Aug; 61(8):2037-44. PubMed ID: 22698916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of B lymphocytes in the pathogenesis of type 1 diabetes.
    Hinman RM; Cambier JC
    Curr Diab Rep; 2014; 14(11):543. PubMed ID: 25189436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bruton's Tyrosine Kinase Synergizes with Notch2 To Govern Marginal Zone B Cells in Nonobese Diabetic Mice.
    Case JB; Bonami RH; Nyhoff LE; Steinberg HE; Sullivan AM; Kendall PL
    J Immunol; 2015 Jul; 195(1):61-70. PubMed ID: 26034172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of autoimmune diabetes in non-obese diabetic mice requires interleukin-21-dependent activation of autoreactive CD8⁺ T cells.
    Chen XL; Bobbala D; Rodriguez GM; Mayhue M; Chen YG; Ilangumaran S; Ramanathan S
    Clin Exp Immunol; 2013 Aug; 173(2):184-94. PubMed ID: 23607664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of MHC-mismatched mouse embryonic stem cell-derived thymic epithelial progenitors and MHC-matched bone marrow prevents autoimmune diabetes.
    Su M; Lin Y; He Z; Lai L
    Stem Cell Res Ther; 2019 Aug; 10(1):239. PubMed ID: 31387620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and therapeutic control of diabetogenic CD8+ T cells.
    Santamaria P
    Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-lymphocytes expressing an Ig specificity recognizing the pancreatic ß-cell autoantigen peripherin are potent contributors to type 1 diabetes development in NOD mice.
    Leeth CM; Racine J; Chapman HD; Arpa B; Carrillo J; Carrascal J; Wang Q; Ratiu J; Egia-Mendikute L; Rosell-Mases E; Stratmann T; Verdaguer J; Serreze DV
    Diabetes; 2016 Jul; 65(7):1977-1987. PubMed ID: 26961115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An antigen-specific immunotherapeutic, AKS-107, deletes insulin-specific B cells and prevents murine autoimmune diabetes.
    Alleva DG; Delpero AR; Sathiyaseelan T; Murikipudi S; Lancaster TM; Atkinson MA; Wasserfall CH; Yu L; Ragupathy R; Bonami RH; Zion TC
    Front Immunol; 2024; 15():1367514. PubMed ID: 38515750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-Reactive T Cells Convert Diabetogenic Insulin-Reactive VH125 B Cells Into Tolerogenic Cells by Reducing Germinal Center T:B Cell Interactions in NOD Mice.
    Pearson JA; Li Y; Majewska-Szczepanik M; Guo J; Zhang L; Liu Y; Wong FS; Wen L
    Front Immunol; 2020; 11():585886. PubMed ID: 33262765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic identification of MHC class I-associated peptidome derived from non-obese diabetic mouse thymus and pancreas.
    Wang L; Li X; Yang S; Chen X; Li J; Wang S; Zhang M; Zheng Z; Zhou J; Wang L; Wu Y
    J Proteomics; 2023 Jan; 270():104746. PubMed ID: 36210013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotavirus acceleration of murine type 1 diabetes is associated with increased MHC class I-restricted antigen presentation by B cells and elevated proinflammatory cytokine expression by T cells.
    Pane JA; Webster NL; Zufferey C; Coulson BS
    Virus Res; 2014 Jan; 179():73-84. PubMed ID: 24246305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-1 pathway-mediated regulation of islet-specific CD4
    Martinov T; Spanier JA; Pauken KE; Fife BT
    Immunoendocrinology (Houst); 2016; 3():. PubMed ID: 27656680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Insulin B Cells Are Poised for Antigen Presentation in Type 1 Diabetes.
    Felton JL; Maseda D; Bonami RH; Hulbert C; Thomas JW
    J Immunol; 2018 Aug; 201(3):861-873. PubMed ID: 29950508
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.